SlideShare una empresa de Scribd logo
1 de 13
Descargar para leer sin conexión
SUV’s - A Brief Overview of Silly Useless Values.

 Todd Charge
 Senior Technologist
 Nuclear Medicine and PET Centre
 Hunter Health Imaging Service




                                   Hunter Health Imaging Service
Standardised Uptake Values



 Quantification has always held a pervasive
          allure for Nuclear Medicine.
 There is a sense that anything that can be
             quantified should be.

         J.W. Keyes Jr. PET Centre North Carolina USA
         Journal Nuclear Medicine 1995; 36:1836-1839




                                            Hunter Health Imaging Service
What are SUV’s?

   A measure of FDG uptake as a function of
    time
   Quantitative evaluation of tumour
    metabolism
   Often used as a measure of malignancy vs.
    benignancy of lesion




                                Hunter Health Imaging Service
Standardised Uptake Value




Data courtesy Mount Vernon Hospital




                                      Hunter Health Imaging Service
Standardised Uptake Value
    Pre Treatment   Post Treatment




     SUV = 18            SUV = 4
                        Hunter Health Imaging Service
Standardised Uptake Value



                  C /(T )
       SUV =
             dose/bodyweight

   Where C/(T) = FDG concentration in tissue
    at time T



                               Hunter Health Imaging Service
Standardised Uptake Value

   Tracer concentration is usually determined
    from the image pixel that shows the highest
    lesion activity
   Average concentration was once used but
    is not routinely in use now




                                Hunter Health Imaging Service
Assumptions of SUV’s

   Negligible free FDG in tissue at time of PET
    scan
   Equilibrium reached between plasma and
    free FDG in tissue
   All tissues are affected in the same way by
    glucose levels




                                 Hunter Health Imaging Service
Variables Influencing SUV’s
   Large number of variables which need to be
    taken into account.
   Patient size
   Measurement times
   Plasma Glucose
   ROI
   Partial Volume Effect
   Camera specifications


                                Hunter Health Imaging Service
Summary
   Use of Lean Body Mass instead of true
    weight
   Take plasma glucose levels into account,
    tumour type & possible treatment effects
   Standardise uptake time, attenuation
    correction, scatter correction and filtering
   Consider ROI placement and use of max
    pixel



                                  Hunter Health Imaging Service
Summary

   Only use SUV within institution and even
    camera specific
   Be careful when using SUV threshold to
    distinguish tumour from normal tissue
   Consider SUV in conjunction with a
    subjective analysis of a lesion.




                                Hunter Health Imaging Service
Summary



   Overall, recognise SUV’s for what they are:


     A helpful clue, but not the final answer.




                                 Hunter Health Imaging Service
References


   DiChiro G, Brooks RA. “PET quantitation: Blessing and Curse.” J Nucl Med
    1988:29;1603-1604
   S Meikle “Quantitative Methods and Factors Affecting SUV Calculation”
    ANZSNM PET Workshop 2003
   JW Keyes “SUV: Standard Uptake or Silly Useless Value?” J Nucl Med
    36:1836-1839, 1995




                                                     Hunter Health Imaging Service

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Electronic portal imaging by rose wekesa
Electronic portal imaging by rose wekesaElectronic portal imaging by rose wekesa
Electronic portal imaging by rose wekesa
 
PET-CT in Oncology
PET-CT in OncologyPET-CT in Oncology
PET-CT in Oncology
 
planning systems in radiotherapy
 planning systems in radiotherapy planning systems in radiotherapy
planning systems in radiotherapy
 
Cobalt & linac
Cobalt & linacCobalt & linac
Cobalt & linac
 
SBRT
SBRTSBRT
SBRT
 
3 dcrt
3 dcrt3 dcrt
3 dcrt
 
TIME DOSE & FRACTIONATION
TIME DOSE & FRACTIONATIONTIME DOSE & FRACTIONATION
TIME DOSE & FRACTIONATION
 
PET-CT Scan(Principles and Basics)
PET-CT Scan(Principles and Basics)PET-CT Scan(Principles and Basics)
PET-CT Scan(Principles and Basics)
 
New Techniques in Radiotherapy
New Techniques in RadiotherapyNew Techniques in Radiotherapy
New Techniques in Radiotherapy
 
Isodose lines
Isodose linesIsodose lines
Isodose lines
 
Total skin electron irradiation
Total skin electron irradiation Total skin electron irradiation
Total skin electron irradiation
 
Image quality in nuclear medicine
Image quality in nuclear medicineImage quality in nuclear medicine
Image quality in nuclear medicine
 
20.pet scan in oncology
20.pet scan in oncology20.pet scan in oncology
20.pet scan in oncology
 
TSET
TSETTSET
TSET
 
Beam Directed Radiotherapy - methods and principles
Beam Directed Radiotherapy - methods and principlesBeam Directed Radiotherapy - methods and principles
Beam Directed Radiotherapy - methods and principles
 
Image Guided Radiotherapy
Image Guided RadiotherapyImage Guided Radiotherapy
Image Guided Radiotherapy
 
TISSUE PHANTOM RATIO - THE PHOTON BEAM QUALITY INDEX
TISSUE PHANTOM RATIO - THE PHOTON BEAM QUALITY INDEXTISSUE PHANTOM RATIO - THE PHOTON BEAM QUALITY INDEX
TISSUE PHANTOM RATIO - THE PHOTON BEAM QUALITY INDEX
 
Katya srs and srt
Katya srs and srtKatya srs and srt
Katya srs and srt
 
Tomotherapy
TomotherapyTomotherapy
Tomotherapy
 
QC Gamma Camera
QC Gamma CameraQC Gamma Camera
QC Gamma Camera
 

Destacado

UACH Fisica en la Oncologia
UACH Fisica en la OncologiaUACH Fisica en la Oncologia
UACH Fisica en la OncologiaWilly H. Gerber
 
Reporting de performances de campagnes d'Ads Twitter - Olympia Bruno Coquatrix
Reporting de performances de campagnes d'Ads Twitter - Olympia Bruno CoquatrixReporting de performances de campagnes d'Ads Twitter - Olympia Bruno Coquatrix
Reporting de performances de campagnes d'Ads Twitter - Olympia Bruno CoquatrixLaurent DENIS
 
Discussion on EnMS - PPT by Mr.Velan
Discussion on EnMS - PPT by Mr.VelanDiscussion on EnMS - PPT by Mr.Velan
Discussion on EnMS - PPT by Mr.Velanmcci175
 
Richard smeltz linkedin presentation
Richard smeltz   linkedin presentationRichard smeltz   linkedin presentation
Richard smeltz linkedin presentationRichard Smeltz
 
Richard smeltz linkedin presentation
Richard smeltz   linkedin presentationRichard smeltz   linkedin presentation
Richard smeltz linkedin presentationRichard Smeltz
 
Gated heart pool scanning - breast uptake
Gated heart pool scanning  - breast uptakeGated heart pool scanning  - breast uptake
Gated heart pool scanning - breast uptaketodd_charge
 
Customer service manifesto
Customer service manifestoCustomer service manifesto
Customer service manifestoRetail360
 
Lietening text 演示文稿
Lietening text 演示文稿Lietening text 演示文稿
Lietening text 演示文稿jiangxue
 
Filtration of radiopharmaceuticals by posidyne neo filters
Filtration of radiopharmaceuticals by posidyne neo filtersFiltration of radiopharmaceuticals by posidyne neo filters
Filtration of radiopharmaceuticals by posidyne neo filterstodd_charge
 

Destacado (20)

UACH Fisica en la Oncologia
UACH Fisica en la OncologiaUACH Fisica en la Oncologia
UACH Fisica en la Oncologia
 
Money
MoneyMoney
Money
 
DSS HORATIO SECURE CLOUD
DSS HORATIO SECURE CLOUDDSS HORATIO SECURE CLOUD
DSS HORATIO SECURE CLOUD
 
Reporting de performances de campagnes d'Ads Twitter - Olympia Bruno Coquatrix
Reporting de performances de campagnes d'Ads Twitter - Olympia Bruno CoquatrixReporting de performances de campagnes d'Ads Twitter - Olympia Bruno Coquatrix
Reporting de performances de campagnes d'Ads Twitter - Olympia Bruno Coquatrix
 
Discussion on EnMS - PPT by Mr.Velan
Discussion on EnMS - PPT by Mr.VelanDiscussion on EnMS - PPT by Mr.Velan
Discussion on EnMS - PPT by Mr.Velan
 
Who
WhoWho
Who
 
Eng
EngEng
Eng
 
Richard smeltz linkedin presentation
Richard smeltz   linkedin presentationRichard smeltz   linkedin presentation
Richard smeltz linkedin presentation
 
Lesson 22
Lesson  22Lesson  22
Lesson 22
 
Richard smeltz linkedin presentation
Richard smeltz   linkedin presentationRichard smeltz   linkedin presentation
Richard smeltz linkedin presentation
 
DSS Media Off Site Storage
DSS Media Off Site StorageDSS Media Off Site Storage
DSS Media Off Site Storage
 
DSS Horatio Secure Cloud
DSS Horatio Secure CloudDSS Horatio Secure Cloud
DSS Horatio Secure Cloud
 
Gated heart pool scanning - breast uptake
Gated heart pool scanning  - breast uptakeGated heart pool scanning  - breast uptake
Gated heart pool scanning - breast uptake
 
Customer service manifesto
Customer service manifestoCustomer service manifesto
Customer service manifesto
 
DSS Horatio Secure Cloud
DSS Horatio Secure CloudDSS Horatio Secure Cloud
DSS Horatio Secure Cloud
 
презентация1
презентация1презентация1
презентация1
 
Lietening text 演示文稿
Lietening text 演示文稿Lietening text 演示文稿
Lietening text 演示文稿
 
Filtration of radiopharmaceuticals by posidyne neo filters
Filtration of radiopharmaceuticals by posidyne neo filtersFiltration of radiopharmaceuticals by posidyne neo filters
Filtration of radiopharmaceuticals by posidyne neo filters
 
Brochure Horatio Secure Cloud
Brochure Horatio Secure CloudBrochure Horatio Secure Cloud
Brochure Horatio Secure Cloud
 
DSS Horatio Secure Cloud Plus
DSS Horatio Secure Cloud PlusDSS Horatio Secure Cloud Plus
DSS Horatio Secure Cloud Plus
 

Similar a SUV- standardised uptake values in pet scanning

19 440 Publication in NAUN journal
19 440 Publication in NAUN journal 19 440 Publication in NAUN journal
19 440 Publication in NAUN journal Pawitra Masa-ah
 
Endpoint considerations in cancer clinical trials
Endpoint considerations in cancer clinical trials Endpoint considerations in cancer clinical trials
Endpoint considerations in cancer clinical trials Bhaswat Chakraborty
 
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...Cytel USA
 
Optimizing Therapeutic Strategies in Castration-Resistant Prostate Cancer
Optimizing Therapeutic Strategies in Castration-Resistant Prostate CancerOptimizing Therapeutic Strategies in Castration-Resistant Prostate Cancer
Optimizing Therapeutic Strategies in Castration-Resistant Prostate Canceri3 Health
 
Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
 Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons... Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...breastcancerupdatecongress
 
Efficacy endpoints in Oncology
Efficacy endpoints in OncologyEfficacy endpoints in Oncology
Efficacy endpoints in OncologyAngelo Tinazzi
 
passive home based monitoring
passive home based monitoringpassive home based monitoring
passive home based monitoringBart de Witte
 
Oncotype dx
Oncotype dxOncotype dx
Oncotype dxNHS
 
Jean Marc Nabholtz : Médicaments biologiques : Critères d’enregistrement et d...
Jean Marc Nabholtz : Médicaments biologiques : Critères d’enregistrement et d...Jean Marc Nabholtz : Médicaments biologiques : Critères d’enregistrement et d...
Jean Marc Nabholtz : Médicaments biologiques : Critères d’enregistrement et d...breastcancerupdatecongress
 
Alan Garber: Value-Conscious Bio-Medical Innovation: Why? How? When?
Alan Garber:  Value-Conscious Bio-Medical Innovation:  Why?  How? When?Alan Garber:  Value-Conscious Bio-Medical Innovation:  Why?  How? When?
Alan Garber: Value-Conscious Bio-Medical Innovation: Why? How? When?capstoneconference09
 
NY Prostate Cancer Conference - A. Vickers - Session 8: Debate 2: Categorical...
NY Prostate Cancer Conference - A. Vickers - Session 8: Debate 2: Categorical...NY Prostate Cancer Conference - A. Vickers - Session 8: Debate 2: Categorical...
NY Prostate Cancer Conference - A. Vickers - Session 8: Debate 2: Categorical...European School of Oncology
 
A new Standard Uptake Values (SUV) Calculation based on Pixel Intensity Values
A new Standard Uptake Values (SUV) Calculation based on Pixel Intensity ValuesA new Standard Uptake Values (SUV) Calculation based on Pixel Intensity Values
A new Standard Uptake Values (SUV) Calculation based on Pixel Intensity ValuesPawitra Masa-ah
 
Recent advances in radiation oncology final (1)
Recent advances in radiation oncology  final (1)Recent advances in radiation oncology  final (1)
Recent advances in radiation oncology final (1)prasanthkandra
 
Improve Outcome in Major Abdominal Surgery with ProAQT
Improve Outcome in Major Abdominal Surgery with ProAQTImprove Outcome in Major Abdominal Surgery with ProAQT
Improve Outcome in Major Abdominal Surgery with ProAQTpicco2
 
Cancer Cervix- NACT vs RT+CCT
Cancer Cervix- NACT vs RT+CCTCancer Cervix- NACT vs RT+CCT
Cancer Cervix- NACT vs RT+CCTSheh Rawat
 
Adjuvant chemotherapy of breast cancer
Adjuvant chemotherapy of breast cancerAdjuvant chemotherapy of breast cancer
Adjuvant chemotherapy of breast cancerGita Bhat
 
Central Adiposity and Mortality after First-Ever Acute Ischemic Stroke
Central Adiposity and Mortality after First-Ever Acute Ischemic StrokeCentral Adiposity and Mortality after First-Ever Acute Ischemic Stroke
Central Adiposity and Mortality after First-Ever Acute Ischemic StrokeErwin Chiquete, MD, PhD
 
Management of Metastatic Cancer Prostate
Management of Metastatic Cancer ProstateManagement of Metastatic Cancer Prostate
Management of Metastatic Cancer ProstateMohamed Abdulla
 
Understanding and interpretation of patient reported outcomes
Understanding and interpretation of patient reported outcomesUnderstanding and interpretation of patient reported outcomes
Understanding and interpretation of patient reported outcomesCochrane.Collaboration
 

Similar a SUV- standardised uptake values in pet scanning (20)

19 440 Publication in NAUN journal
19 440 Publication in NAUN journal 19 440 Publication in NAUN journal
19 440 Publication in NAUN journal
 
Endpoint considerations in cancer clinical trials
Endpoint considerations in cancer clinical trials Endpoint considerations in cancer clinical trials
Endpoint considerations in cancer clinical trials
 
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
 
Optimizing Therapeutic Strategies in Castration-Resistant Prostate Cancer
Optimizing Therapeutic Strategies in Castration-Resistant Prostate CancerOptimizing Therapeutic Strategies in Castration-Resistant Prostate Cancer
Optimizing Therapeutic Strategies in Castration-Resistant Prostate Cancer
 
Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
 Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons... Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
Sophie Taieb : Breast MRI in neoadjuvant chemotherapy : A predictive respons...
 
Efficacy endpoints in Oncology
Efficacy endpoints in OncologyEfficacy endpoints in Oncology
Efficacy endpoints in Oncology
 
passive home based monitoring
passive home based monitoringpassive home based monitoring
passive home based monitoring
 
Oncotype dx
Oncotype dxOncotype dx
Oncotype dx
 
Jean Marc Nabholtz : Médicaments biologiques : Critères d’enregistrement et d...
Jean Marc Nabholtz : Médicaments biologiques : Critères d’enregistrement et d...Jean Marc Nabholtz : Médicaments biologiques : Critères d’enregistrement et d...
Jean Marc Nabholtz : Médicaments biologiques : Critères d’enregistrement et d...
 
Alan Garber: Value-Conscious Bio-Medical Innovation: Why? How? When?
Alan Garber:  Value-Conscious Bio-Medical Innovation:  Why?  How? When?Alan Garber:  Value-Conscious Bio-Medical Innovation:  Why?  How? When?
Alan Garber: Value-Conscious Bio-Medical Innovation: Why? How? When?
 
NY Prostate Cancer Conference - A. Vickers - Session 8: Debate 2: Categorical...
NY Prostate Cancer Conference - A. Vickers - Session 8: Debate 2: Categorical...NY Prostate Cancer Conference - A. Vickers - Session 8: Debate 2: Categorical...
NY Prostate Cancer Conference - A. Vickers - Session 8: Debate 2: Categorical...
 
A new Standard Uptake Values (SUV) Calculation based on Pixel Intensity Values
A new Standard Uptake Values (SUV) Calculation based on Pixel Intensity ValuesA new Standard Uptake Values (SUV) Calculation based on Pixel Intensity Values
A new Standard Uptake Values (SUV) Calculation based on Pixel Intensity Values
 
Recent advances in radiation oncology final (1)
Recent advances in radiation oncology  final (1)Recent advances in radiation oncology  final (1)
Recent advances in radiation oncology final (1)
 
Improve Outcome in Major Abdominal Surgery with ProAQT
Improve Outcome in Major Abdominal Surgery with ProAQTImprove Outcome in Major Abdominal Surgery with ProAQT
Improve Outcome in Major Abdominal Surgery with ProAQT
 
Cancer Cervix- NACT vs RT+CCT
Cancer Cervix- NACT vs RT+CCTCancer Cervix- NACT vs RT+CCT
Cancer Cervix- NACT vs RT+CCT
 
Adjuvant chemotherapy of breast cancer
Adjuvant chemotherapy of breast cancerAdjuvant chemotherapy of breast cancer
Adjuvant chemotherapy of breast cancer
 
Central Adiposity and Mortality after First-Ever Acute Ischemic Stroke
Central Adiposity and Mortality after First-Ever Acute Ischemic StrokeCentral Adiposity and Mortality after First-Ever Acute Ischemic Stroke
Central Adiposity and Mortality after First-Ever Acute Ischemic Stroke
 
Management of Metastatic Cancer Prostate
Management of Metastatic Cancer ProstateManagement of Metastatic Cancer Prostate
Management of Metastatic Cancer Prostate
 
D5 efficacy endpoints in oncology
D5   efficacy endpoints in oncologyD5   efficacy endpoints in oncology
D5 efficacy endpoints in oncology
 
Understanding and interpretation of patient reported outcomes
Understanding and interpretation of patient reported outcomesUnderstanding and interpretation of patient reported outcomes
Understanding and interpretation of patient reported outcomes
 

Último

Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)Mohamed Rizk Khodair
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
World-TB-Day-2023_Presentation_English.pptx
World-TB-Day-2023_Presentation_English.pptxWorld-TB-Day-2023_Presentation_English.pptx
World-TB-Day-2023_Presentation_English.pptxsumanchaulagain3
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...bkling
 
General_Studies_Presentation_Health_and_Wellbeing
General_Studies_Presentation_Health_and_WellbeingGeneral_Studies_Presentation_Health_and_Wellbeing
General_Studies_Presentation_Health_and_WellbeingAnonymous
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfHongBiThi1
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?Ryan Addison
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 

Último (20)

Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
World-TB-Day-2023_Presentation_English.pptx
World-TB-Day-2023_Presentation_English.pptxWorld-TB-Day-2023_Presentation_English.pptx
World-TB-Day-2023_Presentation_English.pptx
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
 
General_Studies_Presentation_Health_and_Wellbeing
General_Studies_Presentation_Health_and_WellbeingGeneral_Studies_Presentation_Health_and_Wellbeing
General_Studies_Presentation_Health_and_Wellbeing
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?The Importance of Mental Health: Why is Mental Health Important?
The Importance of Mental Health: Why is Mental Health Important?
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 

SUV- standardised uptake values in pet scanning

  • 1. SUV’s - A Brief Overview of Silly Useless Values. Todd Charge Senior Technologist Nuclear Medicine and PET Centre Hunter Health Imaging Service Hunter Health Imaging Service
  • 2. Standardised Uptake Values Quantification has always held a pervasive allure for Nuclear Medicine. There is a sense that anything that can be quantified should be. J.W. Keyes Jr. PET Centre North Carolina USA Journal Nuclear Medicine 1995; 36:1836-1839 Hunter Health Imaging Service
  • 3. What are SUV’s?  A measure of FDG uptake as a function of time  Quantitative evaluation of tumour metabolism  Often used as a measure of malignancy vs. benignancy of lesion Hunter Health Imaging Service
  • 4. Standardised Uptake Value Data courtesy Mount Vernon Hospital Hunter Health Imaging Service
  • 5. Standardised Uptake Value Pre Treatment Post Treatment SUV = 18 SUV = 4 Hunter Health Imaging Service
  • 6. Standardised Uptake Value C /(T ) SUV = dose/bodyweight  Where C/(T) = FDG concentration in tissue at time T Hunter Health Imaging Service
  • 7. Standardised Uptake Value  Tracer concentration is usually determined from the image pixel that shows the highest lesion activity  Average concentration was once used but is not routinely in use now Hunter Health Imaging Service
  • 8. Assumptions of SUV’s  Negligible free FDG in tissue at time of PET scan  Equilibrium reached between plasma and free FDG in tissue  All tissues are affected in the same way by glucose levels Hunter Health Imaging Service
  • 9. Variables Influencing SUV’s  Large number of variables which need to be taken into account.  Patient size  Measurement times  Plasma Glucose  ROI  Partial Volume Effect  Camera specifications Hunter Health Imaging Service
  • 10. Summary  Use of Lean Body Mass instead of true weight  Take plasma glucose levels into account, tumour type & possible treatment effects  Standardise uptake time, attenuation correction, scatter correction and filtering  Consider ROI placement and use of max pixel Hunter Health Imaging Service
  • 11. Summary  Only use SUV within institution and even camera specific  Be careful when using SUV threshold to distinguish tumour from normal tissue  Consider SUV in conjunction with a subjective analysis of a lesion. Hunter Health Imaging Service
  • 12. Summary  Overall, recognise SUV’s for what they are: A helpful clue, but not the final answer. Hunter Health Imaging Service
  • 13. References  DiChiro G, Brooks RA. “PET quantitation: Blessing and Curse.” J Nucl Med 1988:29;1603-1604  S Meikle “Quantitative Methods and Factors Affecting SUV Calculation” ANZSNM PET Workshop 2003  JW Keyes “SUV: Standard Uptake or Silly Useless Value?” J Nucl Med 36:1836-1839, 1995 Hunter Health Imaging Service